Literature DB >> 15525848

The prognosis of acute respiratory failure in critically ill cancer patients.

Élie Azoulay1, Guillaume Thiéry, Sylvie Chevret, Delphine Moreau, Michaël Darmon, Anne Bergeron, Kun Yang, Véronique Meignin, Magali Ciroldi, Jean-Roger Le Gall, Abdellatif Tazi, Benoît Schlemmer.   

Abstract

Acute respiratory failure (ARF) in patients with cancer is frequently a fatal event. To identify factors associated with survival of cancer patients admitted to an intensive care unit (ICU) for ARF, we conducted a prospective 5-year observational study in a medical ICU in a teaching hospital in Paris, France. The patients were 203 cancer patients with ARF mainly due to infectious pneumonia (58%), but also noninfectious pneumonia (9%), congestive heart failure (12%), and no identifiable cause (21%). We measured clinical characteristics and ICU and hospital mortality rates.ICU mortality was 44.8% and hospital mortality was 47.8%. Noninvasive mechanical ventilation was used in 79 (39%) patients and conventional mechanical ventilation in 114 (56%), the mortality rates being 48.1% and 75.4%, respectively. Among the 14 patients with late noninvasive mechanical ventilation failure (>48 hours), only 1 survived. The mortality rate was 100% in the 19 noncardiac patients in whom conventional mechanical ventilation was started after 72 hours. By multivariable analysis, factors associated with increased mortality were documented invasive aspergillosis (odds ratio [OR], 2.13; 95% confidence intervals [CI], 1.05-14.74), no definite diagnosis (OR, 3.85; 95% CI, 1.26-11.70), vasopressors (OR, 3.19; 95% CI, 1.28-7.95), first-line conventional mechanical ventilation (OR, 8.75; 95% CI, 2.35-35.24), conventional mechanical ventilation after noninvasive mechanical ventilation failure (OR, 17.46; 95% CI, 5.04-60.52), and late noninvasive mechanical ventilation failure (OR, 10.64; 95% CI, 1.05-107.83). Hospital mortality was lower in patients with cardiac pulmonary edema (OR, 0.16; 95% CI, 0.03-0.72). Survival gains achieved in critically ill cancer patients in recent years extend to patients requiring ventilatory assistance. The impact of conventional mechanical ventilation on survival depends on the time from ICU admission to conventional mechanical ventilation and on the patient's response to noninvasive mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525848     DOI: 10.1097/01.md.0000145370.63676.fb

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  81 in total

1.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic cancer patients.

Authors:  Georg Maschmeyer
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

2.  Opening the doors of the intensive care unit to cancer patients: A current perspective.

Authors:  Silvio A Ñamendys-Silva; Erika P Plata-Menchaca; Eduardo Rivero-Sigarroa; Angel Herrera-Gómez
Journal:  World J Crit Care Med       Date:  2015-08-04

3.  The intensive care support of patients with malignancy: do everything that can be done.

Authors:  Elie Azoulay; Bekele Afessa
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

Review 4.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

5.  Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.

Authors:  Dominique D Benoit; Pieter O Depuydt; Koenraad H Vandewoude; Fritz C Offner; Tom Boterberg; Carole A De Cock; Lucien A Noens; Ann M Janssens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

Review 6.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

7.  Continued survival gains in recent years among critically ill myeloma patients.

Authors:  Vincent Peigne; Katerina Rusinová; Lionel Karlin; Michael Darmon; Jean-Paul Fermand; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

8.  Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial.

Authors:  Elie Azoulay; Virginie Lemiale; Djamel Mokart; Saad Nseir; Laurent Argaud; Frédéric Pène; Loay Kontar; Fabrice Bruneel; Kada Klouche; François Barbier; Jean Reignier; Lilia Berrahil-Meksen; Guillaume Louis; Jean-Michel Constantin; Julien Mayaux; Florent Wallet; Achille Kouatchet; Vincent Peigne; Igor Théodose; Pierre Perez; Christophe Girault; Samir Jaber; Johanna Oziel; Martine Nyunga; Nicolas Terzi; Lila Bouadma; Christine Lebert; Alexandre Lautrette; Naike Bigé; Jean-Herlé Raphalen; Laurent Papazian; Michael Darmon; Sylvie Chevret; Alexandre Demoule
Journal:  JAMA       Date:  2018-11-27       Impact factor: 56.272

9.  Management of Acute Respiratory Failure in Patients With Hematological Malignancy.

Authors:  Rakesh Vadde; Stephen M Pastores
Journal:  J Intensive Care Med       Date:  2016-07-07       Impact factor: 3.510

10.  H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.

Authors:  Thiago Moreno L Souza; Jorge I F Salluh; Fernando A Bozza; Milene Mesquita; Márcio Soares; Fernando C Motta; Melissa Tassano Pitrowsky; Maria de Lourdes Oliveira; Vasiliy P Mishin; Larissa V Gubareva; Anne Whitney; Sandra Amaral Rocco; Vânia Maria C Gonçalves; Venceslaine Prado Marques; Eduardo Velasco; Marilda M Siqueira
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.